The First Affiliated Hospital Of Soochow University

This study tests whether N-acetylcysteine (NAC), a common antioxidant, can treat a severe blood-clotting complication that can occur after a stem cell transplant. The trial enrolls 44 adults diagnosed with this condition and measures improvements in blood counts and organ functio…

This study tests a new approach for adults with a specific type of leukemia (Philadelphia chromosome-positive B-ALL). It combines two types of engineered immune cells: CAR-T cells that attack cancer, and 'feeding' T cells that help the CAR-T cells grow and stay active longer. The…

This study tests a new way to treat non-small cell lung cancer. Doctors take a patient's own immune cells, train them with a special nanovaccine made from the patient's tumor, and then put them back into the body to fight the cancer. The goal is to see if these cells can safely t…

This study tests whether specially engineered T cells (CAR T cells) that target two proteins on cancer cells (CD19 and BCMA) can safely control high-risk multiple myeloma after a stem cell transplant. About 43 participants will receive the CAR T cells and be monitored for side ef…

This study tests a combination of three drugs (chidamide, azacytidine, and a chemotherapy regimen called HAG) in adults aged 18 to 70 with acute myeloid leukemia that has come back or not responded to standard treatment. The goal is to see if this combination can shrink or elimin…

This study tests a new PET/CT scan that uses a special radioactive tracer to find a protein called Nectin-4 on solid tumors like breast, bladder, and lung cancers. The goal is to see if this scan can clearly show where these tumors are in the body, which may help doctors choose b…

This study follows 300 people who have low blood cell counts (cytopenia) lasting at least 4 months but do not yet have myelodysplastic syndromes (MDS). The goal is to see how often these early conditions, called ICUS and CCUS, turn into MDS. Participants are observed over time, a…